ReviewTissue engineering and regenerative medicine2026
Essential Oils in Skin Tissue Engineering: Opportunities, Integration, and Overcoming Challenges.
Review in Tissue engineering and regenerative medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEssential oils (EOs) derived from plants have been utilized for the development of various approaches in biomedical applications due to their superior properties. In particular, their antimicrobial, anti-inflammatory, antioxidant, and wound-healing effects, alongside their biocompatibility and biodegradability, have made EOs a significant complementary agent in tissue regeneration-focused applications. Initial uses of EOs focused primarily on direct application and evaluation of their therapeutic efficacy; however, these approaches have been limited by issues such as volatility, instability, and potential for irritation.
methodsThis review focuses on current perspectives in tissue engineering strategies, based on the biological functions of EO, such as biocompatibility, antimicrobial, anticancer, and antioxidant properties. Based on this comprehensive background of biological functions, current studies addressing nanoparticle systems, smart delivery systems, and wound dressings and coatings have been analyzed to identify existing issues and strategies to tackle these challenges.
resultsIn skin tissue engineering applications, innovative strategies such as nanoparticle encapsulation, integration into smart delivery systems, and the development of wound dressings containing EO have been developed. These advanced approaches offer advantages such as improved EO stability, controlled release, and enhanced efficacy, while also enriching the biofunctionality of the platform. While advanced delivery systems improve the stability of EOs, long-term stability under physiological and clinical conditions remains challenging. However, compared to conventional methods, these advancements strengthen the potential of EOs to drive tissue repair processes in a more controlled and functional manner.
conclusionThe integration of EO-based tissue engineering with nanotechnology offers a promising approach to optimizing the biological effects of these systems and enhancing the success of their application. Although challenges such as safety, biomaterial interactions, and scalability persist, recent advancements are rapidly overcoming these obstacles. EO-based strategies hold significant potential for overcoming current limitations and advancing the field, particularly in skin tissue engineering.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.